Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
YCXGsULAZvxSHb5F
Listen
